Inhalation Sciences Sweden AB Stock NORDIC GROWTH MARKET
Stocks
ISAB
SE0009983893
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
NORDIC GROWTH MARKET
31/01/2024
|
5-day change | 1st Jan Change | ||
| 4.340 SEK | +6.90% |
|
-.--% | - |
| 07-29 | Inhalation Sciences secures financing of up to €0.4m | FW |
| 06-16 | Inhalation Sciences Secures SEK 0.4m Research Grant | FW |
| Market Cap | 7.83M 818K 710K 666K 606K 1.14M 77.97M 1.16M 3.05M 39.15M 3.07M 3.01M 131M | P/E 2024 |
-12.8x | P/E 2025 | -12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 5M 523K 453K 425K 387K 728K 49.79M 740K 1.95M 25M 1.96M 1.92M 83.9M | EV / Sales 2024 |
5.6x | EV / Sales 2025 | 55x |
| Free-Float |
94.25% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +6.90% |
| Manager | Title | Age | Since |
|---|---|---|---|
Manoush Masarrat
CEO | Chief Executive Officer | - | 16/09/2019 |
Per Magnus Gerde
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2005 |
Ulf Wedenberg
PRN | Corporate Officer/Principal | - | 02/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Per Magnus Gerde
BRD | Director/Board Member | - | 01/01/2005 |
Jan Hellqvist
BRD | Director/Board Member | - | 01/09/2022 |
Ulf Ericsson
BRD | Director/Board Member | - | 01/09/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.90% | -.--% | - | - | 899K | |
| -0.33% | +6.77% | +30.41% | +10.89% | 224B | |
| -0.80% | +5.65% | +3.02% | -19.43% | 146B | |
| +0.01% | +8.96% | -14.96% | +31.78% | 142B | |
| +0.45% | +4.75% | -49.96% | +0.76% | 74.19B | |
| -0.65% | +3.85% | +19.05% | +17.18% | 53.99B | |
| -1.41% | +0.08% | -14.95% | -17.29% | 50.85B | |
| -0.84% | +6.49% | +29.89% | +16.85% | 42.22B | |
| +0.28% | +5.07% | +49.00% | +42.68% | 40.75B | |
| -0.65% | +2.88% | -0.99% | +0.96% | 32.86B | |
| Average | +0.30% | +5.30% | +5.61% | +9.38% | 89.57B | |
| Weighted average by Cap. | -0.38% | +6.23% | +6.09% | +8.31% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 11.05M 1.15M 1M 939K 855K 1.61M 110M 1.63M 4.31M 55.21M 4.33M 4.24M 185M | 3.04M 318K 276K 259K 235K 443K 30.27M 450K 1.19M 15.2M 1.19M 1.17M 51.01M |
| Net income | -5.15M -538K -466K -438K -398K -749K -51.23M -761K -2.01M -25.72M -2.02M -1.97M -86.33M | -10.16M -1.06M -921K -864K -786K -1.48M -101M -1.5M -3.96M -50.78M -3.98M -3.9M -170M |
| Net Debt | -4M -418K -363K -340K -310K -583K -39.84M -592K -1.56M -20.01M -1.57M -1.54M -67.14M | -2.83M -296K -256K -241K -219K -412K -28.18M -419K -1.1M -14.15M -1.11M -1.09M -47.48M |
Employees
-
Calendar
Net sales - Rate of surprise
- Stock Market
- Stocks
- ISAB Stock
- ISAB Stock
Select your edition
All financial news and data tailored to specific country editions
